Meanwhile, the ARHGEF28 gene, associated with Rho guanyl-nucleotide exchange factor activity, has been previously reported to correlate with resistance to concurrent chemoradiotherapy in rectal cancer [36]. Here, ARHGEF28 is linked to rectal cancer.